Infante J, Dees EC, Cohen RB, Burris H, O'Neil B, Murphy P, Lee Y, Pappas J, Ecsedy JA, Eton O
Phase 1 study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of MLN8237, a selective Aurora A kinase inhibitor, in the United States
2008;:90-1.
Abstract